ADMA Biologics Inc.

NASDAQ: ADMA · Real-Time Price · USD
16.95
-0.02 (-0.12%)
At close: Aug 15, 2025, 3:59 PM
17.00
0.29%
After-hours: Aug 15, 2025, 07:08 PM EDT

ADMA Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
208.93M 206.77M 197.67M 68.13M 34.79M -3.64M -28.24M -22.83M -40.29M -47.68M -65.9M -70.32M -73.14M -78.28M -71.65M -74.41M -73.61M -74.88M
Depreciation & Amortization
7.91M 7.9M 8.04M 8.21M 8.36M 8.41M 8.33M 8.16M 7.93M 7.56M 7.11M 6.69M 6.25M 5.86M 5.5M 5.21M 4.82M 4.38M
Stock-Based Compensation
18.2M 16.1M 13.62M 9.93M 8.44M 7.22M 6.19M 5.51M 5.13M 4.68M 5.21M 5.36M 4.73M 4.35M 3.49M 2.96M 3.05M 2.96M
Other Working Capital
-3.28M -10.37M -2.78M -6.36M -736.6K 10.18M 7.58M 10.01M 11.78M 7.53M 6.4M 2.95M 3.28M 7.44M 5.49M 3.39M 4.81M 3.32M
Other Non-Cash Items
-104.12M -82.21M -49.17M 68.25M 69.71M 71.15M 39.41M 6.62M 6.87M 6.58M 12.35M 10.97M 9.49M 8.57M 1.75M 1.69M 1.67M 1.65M
Deferred Income Tax
5.04M 3.42M n/a -6.86M -6.77M -6.77M -6.77M 92.85K n/a n/a n/a 140.28K 142.63K 219.98K 220.76K -842.1K -835.48K -910.29K
Change in Working Capital
-59.25M -50.77M -18.54M -28.66M -8.57M -22.12M -10.12M -13.73M -21.08M -19.35M -18.29M -38.44M -33.21M -45.87M -51.68M -45.74M -56.66M -43.79M
Operating Cash Flow
76.71M 101.22M 118.67M 86.05M 73.01M 21.3M 8.8M -16.18M -41.45M -48.22M -59.51M -85.59M -85.72M -105.15M -112.37M -111.12M -121.56M -110.59M
Capital Expenditures
-10.62M -10.56M -8.22M -6.88M -6.89M -5.4M -4.98M -7.32M -9.95M -13.01M -13.91M -13.84M -13.25M -13.78M -13.51M -13.43M -13.53M -13.22M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-473K -368K -364K -581K -225K -225K -210K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-11.1M -10.93M -8.57M -7.23M -6.89M -5.4M -4.98M -7.32M -9.95M -13.01M -13.91M -13.84M -13.25M -13.78M -13.51M -13.43M -13.53M -13.22M
Debt Repayment
-60M -60M -60M -53.58M -23.58M -23.59M -23.6M -25.87K -35.12K -37.74K 51.71M 51.71M 51.71M 51.72M -34.3K 1.02M 1.02M 1.02M
Common Stock Repurchased
3.17M 2.48M n/a n/a -3.38M -2.68M -849.58K -849.58K -1.07M -1.38M -831.3K -831.3K -401.31K -91.37K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-3.19M -3.6M 2.08M -12.34M -16.46M -16.33M -15.52M -2.34M -3.16M -3.25M -7.08M 48.64M 49.05M 49.36M 53.77M -891.6K -889.31K -883.06K
Financial Cash Flow
-63.57M -63.98M -58.3M -66.27M -40.39M -39.79M -38.99M 62.75M 61.49M 60.93M 108.85M 99.93M 108.97M 126.47M 121.05M 99.29M 101.72M 84.54M
Net Cash Flow
2.04M 26.3M 51.8M 12.55M 25.73M -23.88M -35.17M 39.25M 10.1M -300.78K 35.43M 495.45K 10.01M 7.54M -4.83M -25.26M -33.37M -39.27M
Free Cash Flow
66.09M 90.66M 110.45M 79.18M 66.12M 15.91M 3.82M -23.5M -51.39M -61.23M -73.42M -99.43M -98.97M -118.94M -125.88M -124.56M -135.09M -123.81M